Top News
From the Canadian Lymphedema Framework: Save the MUHC Lymphedema Program
The following message is from the Canadian Lymphedema Framework. “After being charitably funded for 18 years, the Lymphedema Program of the McGill...
Read MoreBioCanRx Consultation Survey for Cancer Immunotherapy Research Priorities
The following message is from BioCanRx. “As some of you are aware, BioCanRx – Canada’s Immunotherapy Network, was awarded funding through...
Read MoreCADTH Symposium Travel Awards Program Now Accepting Applications
The following is a message from CADTH. “We are pleased to announce that the 2024 Symposium Travel Awards Program is accepting applications to...
Read MoreCheck Out This Op-Ed From Our Partners at Dense Breasts Canada
Dense Breasts Canada Co-Founder and Executive Director Jennie Dale has penned an opinion piece for The Gazette on Quebec’s new breast cancer...
Read MoreCORD Launches #FightForOurLives Campaign
The Following is a message from the Canadian Organization for Rare Disorders. Attention Rare Disease Community: Last year, the federal...
Read MoreThe Canadian Cancer Survivor Network Holds Open House for World Cancer Day
For the first time since COVID-19, CCSN held its traditional in-person Open House on February 2 to mark World Cancer Day. Jackie Manthorne, CCSN...
Read MoreCanadian Cancer Survivor Network Launches the Canadian Prostate Cancer Guide
The Canadian Cancer Survivor Network (CCSN) is pleased to announce the launch of the Canadian Prostate Cancer Guide aggregator website to bring men...
Read MoreMore Headlines
- Nova Scotia Becomes the Latest Province to Create a Lung Cancer Screening Program
- Priorities for Transforming the Clinical Trials Environment: Ontario’s Ambition to Accelerate Timely Access to Trials and New Therapies
- BC to Test for Cervical Cancer Through HPV Screening
- CADTH calls for Abstract for 2024 Symposium
Upcoming Events
- Apr04Inaugural AACR Oncology Industry Partnering Event: From Cancer Discoveries to Patients
This Event is put on by the American Association for Cancer Research. Cochairs: Michael A. Caligiuri, City of Hope, Duarte, CA Christiana Bardon, MPM | BioImpact Capital, Boston, MA William N. Hait, Johnson & Johnson, New Brunswick, NJ Register today for the Inaugural AACR Oncology Industry Partnering Event: From Cancer Discoveries to Patients, where leading pharmaceutical and biotechnology companies will present their oncology-focused pipelines, emerging
View Event - Apr05
- Apr13Childcan 50 anniversary
This event is put on by Childcan As we come together… …to celebrate 50 years of bringing hope to our kids and their families affected by childhood cancer. Join us for this family friendly gala and enjoy some awesome fun-raising and hope-raising too! There’s something for everyone! Kids can dive into a world of fun with exciting activities, while the young at heart can strike
View Event - Apr23Webinar – How your gut health can affect your blood cancer treatment and quality of life
This event is put on by the Leukemia and Lymphoma Society of Canada. You are what you eat and researchers are learning that this principle can apply to blood cancer treatment and your quality of life! Changes to your ‘gut microbiome’ – the community of microbes, fungi, viruses and their genes in your digestive system – can boost your immune system and benefit your treatment.
View Event - Apr23Webinar – How your gut health can affect your blood cancer treatment and quality of life
This webinar is put on by the Leukemia & Lymphoma Society of Canada You are what you eat and researchers are learning that this principle can apply to blood cancer treatment and your quality of life! Changes to your ‘gut microbiome’ – the community of microbes, fungi, viruses and their genes in your digestive system – can boost your immune system and benefit your treatment.
View Event
Participate
- Broadstreet Cancer Treatment Survey
Dear member: We are conducting a new research study in which you may be interested in participating. We are aiming to understand the thoughts and opinions of Canadians on how new cancer treatments are evaluated, and how decisions about the availability of new treatments should be made. We will be conducting virtual interviews with 20-25 interested and eligible individuals. Virtual interviews will occur in March and April 2024, and participants will be compensated $100 for their time and expertise. To participate you need to:
- Be 18 years of age or older
- Be currently undergoing or having had past treatment for stage I-III breast cancer; stage I-III non-small cell lung cancer; limited stage small cell lung cancer; or stage A or B liver cancer
- Live in Canada
- Be fluent in English
- Complete an eligibility questionnaire about cancer diagnosis and treatment
- BC Ministry of Health – Survey on Minor Ailments and Contraception Service
The BC Ministry of Health has published a survey to receive feedback from the public on the Minor Ailments and Contraception Service (MACS). These are significant change coming for British Columbians and will have an impact on access to care and how patients will soon have an alternative route to access assessment and treatment with medicines through Pharmacists with authority being given to Pharmacists for prescribing in the treatment of minor ailments. This is new for BC and will be coming into effect in the couple of month, based on tentative information. I encourage you to circulate this survey to your members and stakeholders in BC, it is a short survey. The survey will be open from April 12th to April 30th .Participate Now
- Lung Cancer Screening Values (LCSV) study team at McMaster University
We are recruiting 55 and 85-year-olds who can converse in English for a research study. The purpose of this study is to investigate Ontarians’ values, attitudes, and beliefs about lung cancer screening. Participants will be compensated $20 for completing an interview in person (Hamilton, ON), by telephone or video call. If you are interested in participating, please fill out the eligibility survey here: https://dfmgp.mcmaster.ca/surveys/?s=MXFWX8483DJ88RLW We hope to learn what you think about the importance of lung cancer screening, who you think should be screened, and your perspectives on the benefits and harms of lung cancer screening. Your participation can help advance our thinking about lung cancer screening in order to make a potential future lung cancer screening program in Ontario fair, effective, and an efficient use of health care dollars. This research study is part of a doctoral thesis by Manisha Pahwa, a Ph.D. student at McMaster University, and has been reviewed by the Hamilton Integrated Research Ethics Board (project #8310)”Participate Now
Cancer Journey Stories
Plot Twist: Lung Cancer at 33 – Katie Hulan
I am a stage 4 ALK+ lung cancer patient who was diagnosed February 2021 at 33 years old.
Read MoreSurviving Metastatic Prostate Cancer – Derek Lawrence
I first learned that I had prostate cancer from my urologist in 1995, and he told me that I actually had a very aggressive cancer. I had been to my family doctor in 1992 and 1993 for my annual checkup, which was fine; no mention was ever made to me about having a PSA blood test, but I was given a digital rectal exam. Somehow
Read More